
CVS Health Corporation CVS
$ 79.55
0.15%
Quarterly report 2025-Q2
added 07-31-2025
CVS Health Corporation EV/EBITDA Ratio 2011-2025 | CVS
Annual EV/EBITDA Ratio CVS Health Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 16.2 | 8.21 | 9.38 | 10.7 | 8.82 | 8.33 | 11.5 | 11.5 | 9.25 | 8.17 | 8.19 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.2 | 8.17 | 10 |
EV/EBITDA Ratio of other stocks in the Health care industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
19.2 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
9.45 | $ 276.37 | 0.62 % | $ 75.7 B | ||
|
Triple-S Management Corporation
GTS
|
79.5 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
16.1 | - | -0.19 % | $ 2.49 B | ||
|
Humana
HUM
|
21.3 | $ 273.95 | 2.12 % | $ 33 B | ||
|
Centene Corporation
CNC
|
26.4 | $ 40.59 | -0.66 % | $ 21.2 B | ||
|
Molina Healthcare
MOH
|
20.4 | $ 166.33 | -1.28 % | $ 9.55 B | ||
|
UnitedHealth Group Inc.
UNH
|
21.6 | $ 340.29 | -0.45 % | $ 313 B | ||
|
NovoCure Limited
NVCR
|
-243 | $ 13.02 | -2.29 % | $ 1.4 B |